- Report
- September 2026
- 191 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,441GBP
- Report
- January 2026
- 281 Pages
Global
From €2236EUR$2,500USD£1,916GBP
- Report
- August 2026
- 160 Pages
Global
From €2970EUR$3,320USD£2,545GBP
€3712EUR$4,150USD£3,181GBP
- Report
- October 2025
- 160 Pages
Global
From €2827EUR$3,160USD£2,422GBP
€3534EUR$3,950USD£3,027GBP
- Report
- January 2026
- 199 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- September 2026
- 192 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- November 2025
- 188 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- September 2026
- 270 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- September 2026
- 340 Pages
Global
From €5233EUR$5,850USD£4,484GBP
- Report
- January 2026
- 180 Pages
Global
From €4026EUR$4,500USD£3,449GBP
- Report
- January 2026
- 130 Pages
Global
From €4249EUR$4,750USD£3,641GBP
- Report
- March 2026
- 138 Pages
Global
From €4339EUR$4,850USD£3,717GBP
- Report
- July 2026
- 218 Pages
Global
From €4293EUR$4,799USD£3,678GBP
- Report
- June 2026
- 200 Pages
Global
From €2675EUR$2,990USD£2,292GBP
- Report
- April 2026
- 200 Pages
Global
From €2675EUR$2,990USD£2,292GBP
- Report
- May 2026
- 150 Pages
Global
From €5323EUR$5,950USD£4,560GBP
- Report
- May 2026
- 150 Pages
Global
From €5323EUR$5,950USD£4,560GBP
- Report
- January 2026
- 188 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP
- Report
- January 2026
- 191 Pages
Global
From €3171EUR$3,545USD£2,717GBP
€3524EUR$3,939USD£3,019GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more